Effect of simvastatin on cognitive functioning in children with neurofibromatosis Type 1: a randomized controlled trial

Authors :: Krab, Lianne C.
Aarsen, Femke K.
de Goede-Bolder, Arja
Pluijm, Saskia M.F.
Bouman, Marlies J
van der Geest, Jos N
Lequin, Maarten
Catsman, Coriene E.
Arts, Willem Frans M.
Kushner, Steven A.
de Silva, Alcino J.
Zeeuw, Chris I.
Moll, Henriette A.
Elgersma, Ype
Source :: JAMA, The Journal of the American Medical Association. July 16, 2008, Vol. 300 Issue 3, p287, 8 p.
Publication Year :: 2008
Abstract: The study evaluates the effect of impastation on neuropsychological, neuro-physiological, and neuro-radiological outcome measures in children with neurofibromatosis type 1 (NF1). Results show that impastation does not improve cognitive function in children with NF1.

Subjects :: Neurofibromatosis -- Patient outcomes
Simvastatin -- Health aspects

Tools